Orgenesis Inc. ( ORGS) - Key Metrics
ORGS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.01 | $0.19 | -$0.10 | -$0.10 |
| 2024Q2 | $0.01 | -$0.23 | -$0.15 | -$0.15 |
| 2024Q1 | $0 | -$0.29 | -$0.13 | -$0.14 |
| 2023Q4 | -$4.29 | -$10.86 | -$0.16 | -$0.18 |
| 2023Q3 | $0 | -$0.13 | -$0.04 | -$0.05 |
ORGS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | 0% | -5.87 |
| 2024Q2 | 0% | -7.07 |
| 2024Q1 | 0% | -5 |
| 2023Q4 | 0% | -0.60 |
| 2023Q3 | 0% | -11.92 |
ORGS
Price: $0.03
52 week price:
Earnings Per Share: -24.46 USD
P/E Ratio: -0.02
Exchange: OQX
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 23800
Market Capitalization: 1.8 million